drugset / Trial / NCT04886323

Effect of Cold Atmospheric Plasma on Malassezia Folliculitis

NCT04886323

RandomizedParallel-groupTriple-blindTreatment

Summary

The cold atmospheric plasma may provide a new and effective method for the treatment of Malassezia folliculitis. The investigators conduct this randomized controlled trial to evaluate the effectiveness and safety of cold atmospheric plasma on Malassezia folliculitis. Participants entered this double-blind placebo-controlled trial will randomly assign to treatment with either cold atmospheric plasma or antifungal drugs. The differences of treatment effects of the two groups will be observed and compared.

Timeline

Start
2022-08-03
Primary completion
2023-12-17
Completion
2023-12-17

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Itraconazole Small molecule 200 mg

Indications